FDA Set To Bump Defibrillators Up In Risk Class

Law360, New York (January 26, 2011, 4:40 PM EST) -- The U.S. Food and Drug Administration has decided there should be stricter controls on heart defibrillators, in response to thousands of individual complaints about safety problems.

At a meeting on Tuesday, a majority of the advisory committee members indicated that they would support bumping defibrillators up to Class III high-risk medical devices from Class II medium-risk devices. There was no formal vote, however, FDA representatives said.

Class III devices require FDA approval in the form of a premarket approval application.

In November, the FDA called for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.